IQV Gains From Clinical Development Capabilities Amid Low Liquidity
IQVIA(IQV) ZACKS·2024-09-18 00:35
IQVIA Holdings Inc. (IQV) had an impressive run in the past three months. The company's shares have gained 12.5% compared with the 3.4% rally of its industry and the 2.5% rise of the Zacks S&P 500 composite. IQV reported impressive second-quarter 2024 results. Adjusted earnings (excluding 67 cents from nonrecurring items) were $2.6 per share, outpacing the Zacks Consensus Estimate by 2.3% and increasing 2.4% on a year-over-year basis. Total revenues of $3.8 billion surpassed the consensus estimate marginall ...